I den 26- ugers åbne periode i forsøget var de hyppigst observerede laboratoriemæssige abnormaliteter stigninger i creatinin (6, 5%) og øgede CK - værdier hos 2% af børnene.
In the 26-week open-label period of this trial the most frequent laboratory abnormalities observed were creatinine increases (6.5%) and elevated CK values in 2% of child recipients.